Rheinland Biotechnology: Independent Director System (October 2025)
Guilin Rhine Biotechnology Co., Ltd.
Guilin Rhine Biotechnology Co., Ltd.
independent director system
Chapter 1 General Provisions
Article 1 In order to further improve the governance structure of Guilin Rhine Biotechnology Co., Ltd. (hereinafter referred to as the "Company"), regulate the behavior of independent directors, ensure that independent directors independently exercise their powers in accordance with the law, give full play to the role of independent directors in corporate governance, standardize the company's operations, better safeguard the overall interests of the company, and protect the legitimate rights and interests of all shareholders, especially small and medium-sized shareholders, from being harmed, according to the Company Law of the People's Republic of China (hereinafter referred to as the "Company Law"), the Securities Law of the People's Republic of China (hereinafter referred to as the "Securities Law"), the China Securities Regulatory Commission (hereinafter referred to as the China Securities Regulatory Commission) "Administrative Measures for Independent Directors of Listed Companies" and the Shenzhen Stock Exchange (hereinafter referred to as the Shenzhen Stock Exchange) "Stock Listing Rules" and other relevant laws, administrative regulations, departmental rules, normative documents, self-regulatory rules, etc., to formulate this system.
Article 2 Independent directors refer to directors who do not hold other positions in the company other than directors, and have no direct or indirect interest relationship with the company, its major shareholders or actual controllers, or other relationships that may affect their independent and objective judgment.
Independent directors shall perform their duties independently and shall not be influenced by the company, its major shareholders, actual controllers and other units or individuals.
Article 3 Independent directors have the duty of loyalty and diligence to the company and all shareholders. Independent directors shall conscientiously perform their duties in accordance with laws, administrative regulations, provisions of the China Securities Regulatory Commission (hereinafter referred to as the China Securities Regulatory Commission), the business rules of the Shenzhen Stock Exchange and the company's articles of association, play a role in decision-making, supervision and balance, and professional consulting in the board of directors, safeguard the overall interests of the company, and protect the legitimate rights and interests of small and medium-sized shareholders.
Article 4 The company shall provide necessary guarantees for independent directors to perform their duties in accordance with the law.
Article 5 The proportion of independent directors of a company shall not be less than one-third of the board of directors, and shall include at least one accounting professional.
The company should set up an audit committee in the board of directors. The members of the audit committee shall be directors who do not serve as senior managers of the company, among whom the majority shall be independent directors and shall be composed of accounting professionals among the independent directors.
Guilin Rhine Biotechnology Co., Ltd. serves as the convener.
The company can set up special committees such as nomination, remuneration and assessment, and strategy in the board of directors as needed. Independent directors should constitute the majority of the nomination committee and the remuneration and assessment committee and serve as the convener.
Chapter 2 Qualifications and Independence of Independent Directors
Article 6 In principle, independent directors can serve as independent directors in up to three domestic listed companies, including the Company, and should ensure that they have sufficient time and energy to effectively perform their duties as independent directors.
Article 7 The independent directors of a company must maintain their independence. The following persons are not allowed to serve as independent directors of the company:
(1) Personnel working in the company or its affiliated enterprises and their spouses, parents, children, and major social relations;
(2) Directly or indirectly hold more than 1% of the company’s issued shares or are natural person shareholders and their spouses, parents, and children among the top ten shareholders of the company;
(3) Shareholders who directly or indirectly hold more than 5% of the company’s issued shares or persons who hold positions among the top five shareholders of the company and their spouses, parents, and children;
(4) Personnel working in affiliated enterprises of the company’s controlling shareholder or actual controller and their spouses, parents, and children;
(5) Personnel who provide financial, legal, consulting, sponsorship and other services to the company and its controlling shareholders, actual controllers or their respective affiliated enterprises, including but not limited to all members of the project team of the intermediary agency providing services, reviewers at all levels, persons who signed the report, partners, directors, senior managers and principal persons in charge;
(6) Persons who have major business dealings with the company, its controlling shareholders, actual controllers, or their respective subsidiaries, or persons who work in units with major business dealings, their controlling shareholders, or actual controllers;
(7) Persons who have had the circumstances listed in items 1 to 6 in the past twelve months;
(8) Other personnel who are not independent as stipulated in laws, administrative regulations, China Securities Regulatory Commission regulations, stock exchange business rules and company articles of association.
The subsidiaries of the company's controlling shareholders and actual controllers in items 4 to 6 of the preceding paragraph do not include enterprises controlled by the same state-owned asset management institution as the company and which are not affiliated with the company in accordance with relevant regulations.
Guilin Rhine Biotechnology Co., Ltd.
Independent directors should conduct self-examinations on their independence every year and submit the self-examination results to the board of directors. The board of directors should evaluate the independence of serving independent directors every year and issue special opinions, which should be disclosed at the same time as the annual report.
Article 8 Candidates for independent directors shall have good personal moral character, shall not have any circumstances that prohibit them from being nominated as directors of listed companies as stipulated in relevant laws, regulations, normative documents, etc., and shall not have the following bad records:
(1) Subject to administrative penalties from the China Securities Regulatory Commission or criminal penalties from judicial authorities due to securities and futures violations in the past 36 months;
(2) Being investigated by the China Securities Regulatory Commission or judicial authorities for suspected securities and futures crimes, but no clear conclusion has been reached;
(3) Having been publicly condemned by the stock exchange or criticized in three or more notifications in the past thirty six months;
(4) Bad records such as major breach of trust;
(5) During the previous period of serving as an independent director, the board of directors requested the shareholders' meeting to remove him from office because he failed to attend the board of directors meetings in person or entrust other directors to attend two consecutive times, and the period was less than 12 months;
(6) Other circumstances determined by the Shenzhen Stock Exchange.
Article 9 To serve as an independent director, one must meet the following conditions:
(1) Qualified to serve as a director of a listed company in accordance with laws, administrative regulations and other relevant provisions;
(2) Meet the independence requirements stipulated in Article 7 of this system;
(3) Have basic knowledge of the operation of listed companies, be familiar with relevant laws, regulations and rules, and be familiar with the business rules of the Shenzhen Stock Exchange;
(4) Have more than five years of legal, accounting or economic work experience necessary to perform the duties of an independent director;
(5) Have good personal moral character and have no bad records such as major breach of trust;
(6) Other conditions stipulated in laws, administrative regulations, provisions of the China Securities Regulatory Commission, business rules of stock exchanges and the company's articles of association.
Chapter 3 Appointment and Removal of Independent Directors
Guilin Rhine Biotechnology Co., Ltd.
Article 10 The nomination of candidates for independent directors shall be proposed by the company's board of directors and shareholders who individually or jointly hold more than 1% of the company's issued shares, and shall be elected and decided by the shareholders' meeting.
Investor protection institutions established in accordance with the law may publicly request shareholders to entrust them to exercise the right to nominate independent directors on their behalf.
The nominator specified in paragraph 1 of this article shall not nominate as an independent director candidate any person with whom he or she has an interest or other closely related persons who may affect the independent performance of his duties.
Article 11 The term of each independent director is the same as that of other directors of the company. The term is three years. When the term expires, he or she may be re-elected, but the term of re-election shall not exceed six years.
Anyone who has served as an independent director of the company for six consecutive years shall not be nominated as a candidate for independent director of the company within thirty-six months from the date of this fact.
Article 12 The nominee of an independent director shall obtain the consent of the nominee before nomination. The nominator should fully understand the nominee's occupation, education, professional title, detailed work experience, all part-time jobs, and whether he has any bad records such as major breach of trust, etc., and express his opinion on his/her independence and other conditions for serving as an independent director. The nominee shall make a public statement regarding his/her independence and other conditions for serving as an independent director.
Article 13 The nomination committee of the company's board of directors shall review the qualifications of the nominees and formulate clear review opinions.
The company shall, before convening the shareholders' meeting to elect independent directors, disclose relevant content in accordance with Article 12 of this system and the preceding paragraph, and submit relevant materials of all independent director candidates to the Shenzhen Stock Exchange. The relevant submitted materials shall be true, accurate and complete.
The Shenzhen Stock Exchange will review relevant materials of independent director candidates in accordance with regulations, prudently determine whether independent director candidates meet the qualifications and have the right to raise objections. If the Shenzhen Stock Exchange raises objections, the company shall not submit it to the shareholders' meeting for election.
Article 14 When a company's shareholders' meeting elects two or more independent directors, a cumulative voting system shall be implemented. The voting results of small and medium-sized shareholders shall be counted separately and disclosed.
Article 15 Independent director candidates nominated as accounting professionals shall have extensive accounting professional knowledge and experience, and meet at least one of the following conditions:
(1) Possess the qualification of certified public accountant;
(2) Have a senior professional title, associate professor or above, or a doctoral degree in accounting, auditing or financial management;
Guilin Rhine Biotechnology Co., Ltd.
(3) Have a senior professional title in economic management and have more than five years of full-time work experience in professional positions such as accounting, auditing or financial management.
Article 16 Before the expiration of the term of an independent director, the company may remove him from office in accordance with legal procedures. If an independent director is dismissed from his position in advance, the company shall disclose the specific reasons and basis in a timely manner. If an independent director has any objection, the company shall disclose it in a timely manner.
If an independent director fails to comply with the provisions of Paragraph 1 or Paragraph 2 of Article 9 of this System, he shall immediately stop performing his duties and resign from his position. If a person fails to resign, the board of directors shall immediately terminate his/her duties in accordance with regulations after becoming aware or should be aware of the fact.
If an independent director resigns or is dismissed due to the circumstances specified in the preceding paragraph, resulting in the proportion of independent directors on the board of directors or its special committees not complying with the provisions of this system or the company's articles of association, or if there is a lack of accounting professionals among independent directors, the company shall complete the by-election within 60 days from the date of the occurrence of the aforementioned facts.
Article 17 Independent directors may resign before the expiration of their term of office. An independent director who resigns shall submit a written resignation report to the board of directors, describing any circumstances related to his resignation or that he deems necessary to attract the attention of the company's shareholders and creditors. The company should disclose the reasons for the resignation of independent directors and matters of concern. If the resignation of an independent director results in the proportion of independent directors on the board of directors or special committees of the board of directors not complying with the provisions of this system or the company's articles of association, or there is a lack of accounting professionals among the independent directors, the independent director who intends to resign shall continue to perform his duties until the date of the appointment of the new independent director. The company shall complete the by-election within 60 days from the date of resignation of the independent director.
Chapter 4 Responsibilities and performance methods of independent directors
Article 18 Independent directors shall perform the following duties:
(1) Participate in the decision-making of the board of directors and express clear opinions on the matters discussed;
(2) Supervise potential major conflicts of interest between the companies listed in Articles 21, 24, 25 and 26 of this system and their controlling shareholders, actual controllers, directors and senior managers, urge the board of directors to make decisions in line with the overall interests of the company, and protect the legitimate rights and interests of small and medium-sized shareholders;
(3) Provide professional and objective suggestions on the company’s business development and promote the improvement of the board’s decision-making level;
(4) Other duties stipulated in laws, administrative regulations, provisions of the China Securities Regulatory Commission and the company's articles of association.
Guilin Rhine Biotechnology Co., Ltd.
Article 19 In order to give full play to the role of independent directors, in addition to the powers granted to directors by the Company Law and other relevant laws and regulations, independent directors should also exercise the following special powers:
(1) Independently hire intermediaries to audit, consult or verify specific matters of the company;
(2) Propose to the board of directors to convene an extraordinary shareholders’ meeting;
(3) Proposing to convene a board meeting;
(4) Publicly solicit shareholder rights from shareholders in accordance with the law;
(5) Express independent opinions on matters that may damage the rights and interests of the company or small and medium-sized shareholders;
(6) Other powers stipulated in laws, administrative regulations, provisions of the China Securities Regulatory Commission and the company's articles of association. The exercise of the powers listed in items 1 to 3 of the preceding paragraph by independent directors shall be subject to the consent of more than half of all independent directors.
If an independent director exercises the powers listed in paragraph 1, the company shall disclose it in a timely manner. If the above powers cannot be exercised normally, the company shall disclose the specific circumstances and reasons.
Article 20 Independent directors shall attend board meetings in person. If he is unable to attend the meeting in person for some reason, the independent director shall review the meeting materials in advance, form a clear opinion, and authorize other independent directors in writing to attend on his behalf.
If an independent director fails to attend the board of directors' meeting in person for two consecutive times and does not entrust another independent director to attend on his behalf, the company's board of directors shall propose to convene a shareholders' meeting to remove the independent director from his duties within 30 days from the date of occurrence of this fact.
Article 21 The following matters shall be submitted to the board of directors for review after being approved by more than half of all independent directors of the company:
(1) Related transactions that should be disclosed;
(2) Plans for the company and relevant parties to change or waive their commitments;
(3) The decisions made and measures taken by the board of directors of the acquired company regarding the acquisition;
(4) Other matters stipulated in laws, administrative regulations, provisions of the China Securities Regulatory Commission and the company's articles of association.
Article 22 The company shall regularly or irregularly hold meetings attended by all independent directors (hereinafter referred to as special meetings of independent directors). The matters listed in Items 1 to 3 of Paragraph 1 of Article 19 and Article 21 of this system shall be reviewed by special meetings of independent directors.
Special meetings of independent directors can study and discuss other matters of the company as needed.
Special meetings of independent directors shall be convened and presided over by an independent director jointly elected by more than half of the independent directors.
Guilin Rhine Biotechnology Co., Ltd. holds; when the convener fails or is unable to perform his duties, two or more independent directors can convene themselves and elect a representative to preside over the meeting.
The company shall provide convenience and support for the convening of special meetings of independent directors.
Article 23 Independent directors shall perform their duties in the special committee of the company's board of directors in accordance with laws, administrative regulations, regulations of the China Securities Regulatory Commission, business rules of the stock exchange and the company's articles of association. Independent directors shall attend the meeting of the special committee in person. If they are unable to attend the meeting in person for any reason, they shall review the meeting materials in advance, form clear opinions, and entrust other independent directors in writing to attend on their behalf. When independent directors pay attention to major company matters within the scope of the special committee's responsibilities while performing their duties, they can promptly submit them to the special committee for discussion and review in accordance with the procedures.
The company shall stipulate the composition, responsibilities, etc. of the special committees in the company's articles of association in accordance with the provisions of this system, and formulate work procedures for the special committees to clarify the personnel composition, term of office, scope of responsibilities, rules of procedure, file preservation and other related matters of the special committees. If the relevant competent departments of the State Council have other provisions on the convener of the special committee, such provisions shall prevail.
Article 24 The Audit Committee of the company's board of directors is responsible for reviewing the company's financial information and its disclosure, supervising and evaluating internal and external audit work and internal control. The following matters shall be submitted to the board of directors for review after being approved by more than half of all members of the audit committee:
(1) Disclose financial information and internal control evaluation reports in financial accounting reports and periodic reports;
(2) Appoint or dismiss the accounting firm that handles the company’s audit business;
(3) Appoint or dismiss the company’s financial director;
(4) Changes in accounting policies, accounting estimates or correction of major accounting errors due to reasons other than changes in accounting standards;
(5) Other matters stipulated in laws, administrative regulations, provisions of the China Securities Regulatory Commission and the company's articles of association.
The Audit Committee shall hold at least one meeting every quarter. Extraordinary meetings may be convened upon the proposal of two or more members or when the convener deems it necessary. Meetings of the Audit Committee must be attended by more than two-thirds of the members.
Article 25 The Nomination Committee of the Company’s Board of Directors is responsible for formulating the selection criteria and procedures for directors and senior managers, selecting and reviewing candidates for directors and senior managers and their qualifications, and making recommendations to the Board of Directors on the following matters:
(1) Nominate or appoint or remove directors;
Guilin Rhine Biotechnology Co., Ltd.
(2) Appoint or dismiss senior managers;
(3) Other matters stipulated in laws, administrative regulations, provisions of the China Securities Regulatory Commission and the company's articles of association.
If the board of directors fails to adopt the recommendations of the nomination committee or does not fully adopt them, it shall record the opinions of the nomination committee and the specific reasons for failure to adopt them in the board resolution and disclose them.
Article 26 The Remuneration and Assessment Committee of the Company's Board of Directors is responsible for formulating and conducting assessment standards for directors and senior managers, formulating and reviewing remuneration policies and plans for directors and senior managers, and making recommendations to the Board of Directors on the following matters:
(1) Remuneration of directors and senior managers;
(2) Formulate or change equity incentive plans and employee stock ownership plans, and ensure that incentive objects are granted rights and the conditions for exercising their rights are met;
(3) Directors and senior managers arrange shareholding plans for the subsidiaries to be spun off;
(4) Other matters stipulated in laws, administrative regulations, provisions of the China Securities Regulatory Commission and the company's articles of association.
If the board of directors fails to adopt or fully adopts the recommendations of the Remuneration and Appraisal Committee, it shall record the opinions of the Remuneration and Appraisal Committee and the specific reasons for failure to adopt them in the resolution of the board of directors and disclose them.
Article 27 Independent directors shall continue to pay attention to the implementation of board resolutions related to the matters listed in Articles 21, 24, 25 and 26 of this system. If they find that there is a violation of laws, administrative regulations, provisions of the China Securities Regulatory Commission, business rules of the stock exchange and the provisions of the company's articles of association, or violations of the resolutions of the shareholders' meeting and the board of directors, they shall report to the board of directors in a timely manner and may require the company to make a written explanation. If disclosure matters are involved, the company shall disclose them in a timely manner.
If the company fails to make explanations or timely disclosures in accordance with the provisions of the preceding paragraph, the independent directors may report to the China Securities Regulatory Commission and the stock exchange.
Article 28 If an independent director votes against or abstains from voting on a board resolution, he shall explain the specific reasons and basis, the legality and compliance of the matters involved in the resolution, possible risks, and the impact on the rights and interests of the company and small and medium-sized shareholders. When a company discloses board resolutions, it shall also disclose the dissenting opinions of independent directors and state them in the board resolutions and meeting minutes.
Article 29 Before a board meeting, independent directors may communicate with the secretary of the board of directors to inquire about matters to be considered, request supplementary materials, provide opinions and suggestions, etc. The board of directors and relevant personnel should carefully study the issues, requirements and opinions raised by the independent directors, and provide timely feedback to the independent directors on the implementation status of amendments to the proposals.
Guilin Rhine Biotechnology Co., Ltd.
Article 30 Independent directors shall work on-site at the company for no less than fifteen days each year.
In addition to attending shareholders' meetings, the board of directors and its special committees, and special meetings of independent directors as required, independent directors can perform their duties by regularly obtaining information on the company's operations and other information, listening to management reports, communicating with the person in charge of the internal audit agency and the accounting firm that handles the company's audit business and other intermediaries, conducting on-site inspections, and communicating with small and medium-sized shareholders.
Article 31 The company should improve the communication mechanism between independent directors and small and medium-sized shareholders, so that independent directors can verify issues raised by investors in a timely manner with the company.
Independent directors can publish correspondence addresses or e-mails to communicate with investors, accept investor inquiries and complaints, proactively investigate situations that damage the legitimate rights and interests of the company and small and medium-sized investors, and promptly respond to investors with the investigation results.
Article 32 Independent directors shall perform their duties as directors in accordance with the law, fully understand the company's business operations and the content of board meetings, safeguard the interests of the company and all shareholders, and pay special attention to the protection of the legitimate rights and interests of small and medium-sized shareholders.
If conflicts arise between the company's shareholders or directors and have a significant impact on the company's operation and management, the independent directors should proactively perform their duties and safeguard the overall interests of the listed company.
Article 33 The company's board of directors, its special committees, and special meetings of independent directors shall prepare meeting minutes in accordance with regulations, and the opinions of independent directors shall be stated in the meeting minutes. Independent directors should sign and confirm the meeting minutes.
Independent directors should make work records and record in detail the performance of their duties. Information obtained by independent directors during the performance of their duties, relevant meeting minutes, communication records with company and intermediary agency staff, etc., form an integral part of the work records. For important contents in work records, independent directors may require the secretary of the board of directors and other relevant personnel to sign for confirmation, and the company and relevant personnel shall cooperate.
The work records of independent directors and the information provided by the company to independent directors must be kept for at least ten years.
Article 34 Independent directors shall submit an annual work report to the company's annual shareholders' meeting, explaining the performance of their duties. The annual work report should include the following contents:
(1) Number of attendances at the board of directors, methods and voting conditions, and number of attendances at shareholders’ meetings;
(2) Participation in the work of special committees of the board of directors and special meetings of independent directors;
(3) Review of matters listed in Articles 21, 24, 25 and 26 of this System and the exercise of the special powers of independent directors listed in Paragraph 1 of Article 19 of this System;
Guilin Rhine Biotechnology Co., Ltd.
(4) Major matters, methods and results of communication with the internal audit institution and the accounting firm that undertakes the company’s audit business regarding the company’s financial and business conditions;
(5) Communication status with small and medium-sized shareholders;
(6) The time, content, etc. of working on-site at the company;
(7) Other circumstances in the performance of duties.
The annual performance report of independent directors shall be disclosed at the latest when the company issues notice of the annual shareholders' meeting.
Article 35 Independent directors shall continue to strengthen their study of securities laws, regulations and rules, and continuously improve their ability to perform their duties. The China Securities Regulatory Commission, stock exchanges, and China Association of Listed Companies can provide relevant training services.
Chapter 5 Duty Performance Guarantee for Independent Directors
Article 36 The company shall ensure that independent directors have the same right to know as other directors. In order to ensure that independent directors effectively exercise their powers, the company should regularly inform independent directors of the company's operations, provide information, and organize or cooperate with independent directors to conduct on-site inspections and other work.
Before the board of directors considers major and complex matters, the company can organize independent directors to participate in research and demonstration and other aspects, fully listen to the opinions of independent directors, and provide timely feedback to independent directors on the adoption of opinions.
Article 37 The company shall promptly issue board meeting notices to independent directors, provide relevant meeting materials no later than the notice period for board meetings stipulated in laws, administrative regulations, the provisions of the China Securities Regulatory Commission or the company's articles of association, and provide effective communication channels for independent directors; if a special committee of the board of directors convenes a meeting, the company shall in principle provide relevant materials and information no later than three days before the special committee meeting. The company shall keep the above meeting materials for at least ten years.
If two or more independent directors believe that the information is incomplete, the argument is insufficient or untimely, they may submit a written proposal to the board of directors to postpone the meeting or postpone the consideration of the matter, and the board of directors shall adopt it.
In principle, meetings of the Board of Directors and special committees shall be held on site. On the premise of ensuring that all participating directors can fully communicate and express their opinions, the meeting may be held by video, telephone or other means in accordance with procedures when necessary.
Article 38 The company should provide the necessary working conditions and personnel support for independent directors to perform their duties, and designate specialized departments and personnel such as the secretary of the board of directors to assist independent directors in performing their duties.
The secretary of the board of directors shall ensure that independent directors communicate with other directors, senior managers and other relevant personnel
The smooth flow of information between Guilin Rhine Biotechnology Co., Ltd. ensures that independent directors can obtain sufficient resources and necessary professional advice when performing their duties.
Article 39 When independent directors exercise their powers, the company’s directors, senior managers and other relevant personnel shall cooperate and shall not refuse, obstruct or conceal relevant information, or interfere with their independent exercise of powers. If independent directors encounter obstacles in exercising their powers in accordance with the law, they may explain the situation to the board of directors, require directors, senior managers and other relevant personnel to cooperate, and record the specific circumstances and resolution of the obstacles in their work records; if the obstacles still cannot be eliminated, they may report to the China Securities Regulatory Commission and the Shenzhen Stock Exchange.
If the performance of duties by an independent director involves information that should be disclosed, the company shall handle the disclosure matters in a timely manner; if the company does not disclose the information, the independent director may directly apply for disclosure or report to the China Securities Regulatory Commission and the Shenzhen Stock Exchange.
The China Securities Regulatory Commission and the Shenzhen Stock Exchange should maintain smooth communication channels for independent directors.
Article 40 The company shall bear the reasonable expenses required for independent directors to hire professional institutions and exercise other powers.
Article 41 The company shall provide independent directors with allowances commensurate with their responsibilities. The standard of allowances shall be formulated by the board of directors, reviewed and approved by the shareholders' meeting, and disclosed in the company's annual report. In addition to the above-mentioned allowances, independent directors shall not obtain other benefits from the company, its major shareholders, actual controllers or interested units and personnel.
Article 42 The company may establish a liability insurance system for independent directors to reduce the risks that may arise from the normal performance of duties by independent directors.
Chapter 6 Supplementary Provisions
Article 43 Matters not covered by this system shall be implemented in accordance with relevant national laws, regulations and the company's articles of association. If this system is inconsistent with the relevant provisions of laws, regulations, other normative documents and the Articles of Association, the provisions of the relevant laws, regulations, other normative documents and the Articles of Association shall prevail.
Article 44 Modification and entry into force of this system
This independent director system is revised and interpreted by the board of directors and will take effect after approval by the shareholders' meeting.
Board of Directors of Guilin Rhine Biotechnology Co., Ltd.
October 28, 2025